Literature DB >> 25753627

Identification of aminoglycoside-resistant Pseudomonas aeruginosa producing RmtG 16S rRNA methyltransferase in a cystic fibrosis patient.

Gabriela Rodrigues Francisco1, Sandra Terezinha Rodrigues Nora1, Maria Fernanda Campagnari Bueno1, Luiz Vicente Ribeiro Ferreira da Silva Filho2, Doroti de Oliveira Garcia3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25753627      PMCID: PMC4394813          DOI: 10.1128/AAC.04607-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  rmtD2, a new allele of a 16S rRNA methylase gene, has been present in Enterobacteriaceae isolates from Argentina for more than a decade.

Authors:  Nathalie Tijet; Patricia Andres; Catherine Chung; Celeste Lucero; Donald E Low; Marcelo Galas; Alejandra Corso; Alejandro Petroni; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  High prevalence of metallo-beta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil.

Authors:  Yohei Doi; Angela C R Ghilardi; Jennifer Adams; Doroti de Oliveira Garcia; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

3.  Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day.

Authors:  R K Gautom
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Novel 16S rRNA methyltransferase RmtH produced by Klebsiella pneumoniae associated with war-related trauma.

Authors:  Jessica A O'Hara; Patrick McGann; Erik C Snesrud; Robert J Clifford; Paige E Waterman; Emil P Lesho; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

5.  Coproduction of 16S rRNA methyltransferase RmtD or RmtG with KPC-2 and CTX-M group extended-spectrum β-lactamases in Klebsiella pneumoniae.

Authors:  Maria Fernanda C Bueno; Gabriela R Francisco; Jessica A O'Hara; Doroti de Oliveira Garcia; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

6.  A general method for detecting and sizing large plasmids.

Authors:  B M Barton; G P Harding; A J Zuccarelli
Journal:  Anal Biochem       Date:  1995-04-10       Impact factor: 3.365

7.  Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.

Authors:  Barry Curran; Daniel Jonas; Hajo Grundmann; Tyrone Pitt; Christopher G Dowson
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

8.  Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.

Authors:  Yohei Doi; Doroti de Oliveira Garcia; Jennifer Adams; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

Review 9.  Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update.

Authors:  Jun-ichi Wachino; Yoshichika Arakawa
Journal:  Drug Resist Updat       Date:  2012-06-04       Impact factor: 18.500

10.  16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.

Authors:  Yohei Doi; Yoshichika Arakawa
Journal:  Clin Infect Dis       Date:  2007-05-21       Impact factor: 9.079

View more
  3 in total

1.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

Review 2.  Research Updates of Plasmid-Mediated Aminoglycoside Resistance 16S rRNA Methyltransferase.

Authors:  Weiwei Yang; Fupin Hu
Journal:  Antibiotics (Basel)       Date:  2022-07-07

Review 3.  The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies.

Authors:  R Frèdi Langendonk; Daniel R Neill; Joanne L Fothergill
Journal:  Front Cell Infect Microbiol       Date:  2021-04-16       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.